Explore the latest in rheumatoid arthritis, including recent advances in treatment of RA and in prevention of its systemic complications.
This cohort study compares the delays in tumor necrosis factor inhibitor (TNFi) initiation because of insurance among children enrolled in public and private insurance plans.
This cohort study compares incidence of Alzheimer disease and related dementia among Medicare patients with rheumatoid arthritis using disease-modifying antirheumatic drugs.
This JAMA Patient Page describes the risk factors, signs and symptoms, diagnosis, treatment, and prognosis factors of rheumatoid arthritis.
This cohort study examines whether seropositive rheumatoid arthritis is associated with an increased risk of subsequently developing primary open-angle glaucoma among adults in Korea.
This cohort study compares COVID-19 incidence, risk, outcome severity, and treatment response between immunocompromised individuals and those without immune dysfunction conditions before and after SARS-CoV-2 vaccination.
This randomized clinical trial assesses the effect of therapeutic drug monitoring vs standard therapy on sustained disease control without disease worsening among patients with immune-mediated inflammatory diseases (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, ulcerative colitis, Crohn disease, or psoriasis) undergoing maintenance therapy with infliximab.
A 71-year-old man with rheumatoid arthritis and diabetes presented with pain and ulcers in the pharynx and a defect involving the entire soft palate on the left. What is your diagnosis?
This cohort study examines the association between socioeconomic status and functional status among patients with rheumatoid arthritis and evaluates the association between socioeconomic status and functional declines over time in patients who received at least some rheumatology care.
This randomized trial compares the effects of half-dose conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) vs stable-dose csDMARDs on the risk of flares in patients with rheumatoid arthritis in sustained remission.
This randomized trial assesses the effect of therapeutic drug monitoring vs standard therapy on clinical remission at 30 weeks among patients with immune-mediated inflammatory diseases (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, ulcerative colitis, Crohn disease, or psoriasis) initiating infliximab therapy.
This Teachable Moment discusses the importance of the patient history in guiding diagnosis and treatment and offers strategies to overcome barriers in obtaining a thorough medication history.
This cross-sectional study examines subjective vs objective responses to placebo administration in clinical trials on patients with rheumatoid arthritis.
This case-control study examines the inflammatory CNS event outcome among patients with an autoimmune disease who were treated with tumor necrosis factor inhibitors.
This systematic review and meta-analysis examines whether biologic treatment of inflammatory bowel disease, rheumatoid arthritis, or psoriasis is associated with increased risk of melanoma compared with conventional systemic therapy.
This cohort study evaluates the existence of language and indexing biases among Chinese-sponsored randomized clinical trials on drug interventions.
Customize your JAMA Network experience by selecting one or more topics from the list below.